Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Greenberg HE et al. | A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. | 2000 | J Clin Pharmacol | pmid:11185674 |
| Laguna MS et al. | [Thromboxane B2 and platelet derived growth factor in essential thrombocythemia treated with anagrelide]. | 2000 | Medicina (B Aires) | pmid:11188949 |
| Li G et al. | Ischemic preconditioning enhances donor lung preservation in canine lung transplantation. | 1998 | Chin. Med. J. | pmid:11189228 |
| Guo Q et al. | [Influence of moderate hypothermia on the contents of 6-KETO-PGF1 alpha and TXB2 in brain tissues after cardiac arrest and resuscitation in dogs]. | 1998 | Hunan Yi Ke Da Xue Xue Bao | pmid:11189396 |
| Feldman M et al. | A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women. | 2001 | Clin. Appl. Thromb. Hemost. | pmid:11190906 |
| Sunose Y et al. | The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. | 2001 | J. Am. Coll. Surg. | pmid:11192923 |
| Arifah AK et al. | Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep. | 2001 | Am. J. Vet. Res. | pmid:11197566 |
| Giedrojć J et al. | [Interaction of platelets with monocytes with regard to arachidonic acid metabolites]. | 2000 | Prz. Lek. | pmid:11199865 |
| Ames PR et al. | Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study. | 2000 | Lupus | pmid:11199924 |
| Wang ZG et al. | Can endothelial seeding enhance patency and inhibit neointimal hyperplasia? Experimental studies and clinical trial of endothelial seeded venous prostheses. | 2000 | Int Angiol | pmid:11201596 |
| MacKay RJ et al. | Effect of eltenac in horses with induced endotoxaemia. | 2000 | Equine Vet J Suppl | pmid:11202378 |
| Alric L et al. | Reactive oxygen intermediates and eicosanoid production by kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4. | 2000 | Inflamm. Res. | pmid:11211921 |
| Demasi M et al. | Assay of cyclooxygenase-1 and 2 in human monocytes. | 2000 | Inflamm. Res. | pmid:11211927 |
| Yang G et al. | Effects of prostaglandins and leukotrienes on hypoxic pulmonary vasoconstriction in rats. | 2000 | J. Tongji Med. Univ. | pmid:11215045 |
| Vagnoni KE et al. | The influence of the phase of the estrous cycle on sheep endometrial tissue response to lipopolysaccharide. | 2001 | J. Anim. Sci. | pmid:11219456 |
| Robinson JS et al. | Prostaglandin E, thromboxane B2 and 6-oxo-prostaglandin F1 alpha in amniotic fluid and maternal plasma of rhesus monkeys (Macaca mulatta) during the latter third of gestation. | 1979 | J. Endocrinol. | pmid:112214 |
| Kawaguchi A et al. | Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity. | 2001 | Life Sci. | pmid:11228102 |
| Seno K et al. | Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'. | 2001 | Bioorg. Med. Chem. Lett. | pmid:11229777 |
| Wight NJ et al. | Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production. | 2001 | Gastroenterology | pmid:11231941 |
| Li G et al. | Cardiac ischemic preconditioning improves lung preservation in valve replacement operations. | 2001 | Ann. Thorac. Surg. | pmid:11235719 |